The Sooner the Better? How Symptom Interval Correlates With Outcome in Children and Adolescents With Solid Tumors: Regression Tree Analysis of the Findings of a Prospective Study

Abstract

Background. The potential impact of diagnostic delays on patients' outcomes is a debated issue in pediatric oncology and discordant results have been published so far. We attempted to tackle this issue by analyzing a prospective series of 351 consecutive children and adolescents with solid malignancies using innovative statistical tools. Methods. To address the nonlinear complexity of the association between symptom interval and overall survival (OS), a regression tree algorithm was constructed with sequential binary splitting rules and used to identify homogeneous patient groups vis-à-vis functional relationship between diagnostic delay and OS. Results. Three different groups were identified: group A, with localized disease and good prognosis (5-year OS 85.4%); group B, with locally or regionally advanced, or metastatic disease and intermediate prognosis (5-year OS 72.9%), including neuroblastoma, Wilms tumor, nonrhabdomyosarcoma soft tissue sarcoma, and germ cell tumor; and group C, with locally or regionally advanced, or metastatic disease and poor prognosis (5-year OS 45%), including brain tumors, rhabdomyosarcoma, and bone sarcoma. The functional relationship between symptom interval and mortality risk differed between the three subgroups, there being no association in group A (hazard ratio [HR]: 0.96), a positive linear association in group B (HR: 1.48), and a negative linear association in group C (HR: 0.61). Conclusions. Our analysis suggests that at least a subset of patients can benefit from an earlier diagnosis in terms of survival. For others, intrinsic aggressiveness may mask the potential effect of diagnostic delays. Based on these findings, early diagnosis should remain a goal for pediatric cancer patients. Pediatr Blood Cancer 2016;63:479-485. C 2015Wiley Periodicals, Inc.

Adolescents’ Health Awareness and Understanding of Cancer and Tumor Prevention: When and Why an Adolescent Decides to Consult a Physician

“…The potential impact of symptom interval on patient outcomes is still a debated issue in pediatric oncology, and published results have been discordant. While the intrinsic biological aggressiveness of a tumor clearly plays a major part in determining the symptom interval, some studies have reported that this time lag could negatively affect a patient's chances of survival, especially for certain kinds of tumor . A recent study by our group showed that the correlation between symptom interval and survival is a complex, heterogeneous phenomenon, but at least a subset of patients can benefit from an earlier diagnosis in survival terms .…”

“…It can only come to light if patients report their symptoms to a physician . A common feature of cancer patients in this age group is regrettably the time elapsing before their disease is diagnosed, which is much longer than in the case of children . The potential impact of symptom interval on patient outcomes is still a debated issue in pediatric oncology, and published results have been discordant.…”

Navigating chronic pain: how taking a few wrong turns can miss sinister pathology

“…A long time to diagnosis for tumours is often associated with worse outcome, but this is not universal 16. In Ewing sarcoma, longer histories are not associated with worse outcome 13 17–19.…”

Measuring the efficacy of a project for adolescents and young adults with cancer: A study from the Milan Youth Project

“…Research is another key issue for programs dedicated to AYA. Several studies on AYA have been conducted by the INT Youth Project staff (some already published, others ongoing) on matters such as psychosocial support needs, epidemiology, clinical outcomes, and basic science studies on tumor biology across the age spectrum …”